Nonalcoholic fatty liver disease (NAFLD) is a growing worldwide epidemic and an important
risk factor for the development of insulin resistance, type 2 diabetes, nonalcoholic …

Purpose of Review The global prevalence of type 2 diabetes (T2D) is escalating at alarming
rates, demanding the development of additional classes of therapeutics to further reduce the …

This article describes a 3-stage continuum of evidence-based strategies and activities that
can be used by dietetics professionals to establish community food security. Stage 1 creates …

… The ℒA, ℒC, ℒD and ℒE surface loops 12 are shown. The position of the Phe 43 cavity
involved in CD4 binding is indicated by an asterisk. The gp120 surface implicated in binding to …

Brown (BAT) and white (WAT) adipose tissues play distinct roles in maintaining whole-body
energy homeostasis, and their dysfunction can contribute to non-alcoholic fatty liver disease (…

Elevated liver de novo lipogenesis contributes to non-alcoholic steatohepatitis (NASH) and
can be inhibited by targeting acetyl-CoA carboxylase (ACC). However, hypertriglyceridemia …

Caloric restriction that promotes weight loss is an effective strategy for treating non-alcoholic
fatty liver disease and improving insulin sensitivity in people with type 2 diabetes 1 . Despite …

A human immunodeficiency virus type 1 (HIV-1) mutant lacking the V1 and V2 variable
loops in the gp120 exterior envelope glycoprotein replicated in Jurkat lymphocytes with only …

Human immunodeficiency virus type 1 (HIV-1) requires the presence of specific chemokine
receptors in addition to CD4 to enter target cells. The chemokine receptor CCR5 is used by …

Intestinal dysbiosis contributes to obesity and insulin resistance, but intervening with antibiotics,
prebiotics, or probiotics can be limited by specificity or sustained changes in microbial …